DL-氨基谷氨酰胺 [氨鲁米特]，DL-Aminoglutethimide；pharmaceutical secondary standard, certified reference material

Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards

 

DL-Aminoglutethimide is a derivative of the sedative glutethimide. Originally introduced as an anticonvulsant, it was found to cause adrenal insufficiency. Blocks adrenal steroidogenesis by inhibiting the enzymatic conversion of cholesterol to pregnenolone. It also blocks the peripheral conversion (aromatization) of androgenic precursors to estrogens. The D-isomer is 30 times more potent at inhibiting aromatase activity, whereas the L-isomer is more potent at inhibiting cholesterol side-chain cleavage (steroidogenesis).

 

These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.

 

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

 

To see an example of a Certificate of Analysis for this material enter LRAC8223 in the Documents slot below. This is an example certificate only and may not be the lot that you receive.